Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06063031Not ApplicableUnknown

Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition

Role: collaborator

NCT05633849Not ApplicableCompleted

Evaluation of the Effect of Pro Resolve® Sports on Treatment of Patients With Symptomatic Knee Osteoarthritis

Role: lead

NCT02947100Phase 1Terminated

Omega-3 Fatty Acids in Sickle Cell Disease

Role: collaborator

NCT02518672Phase 2Terminated

Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)

Role: collaborator

All 4 trials loaded